UK markets close in 6 hours 9 minutes

Fresenius Medical Care AG & Co. KGaA (FMCQF)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
61.000.00 (0.00%)
At close: 12:43PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close61.00
Open61.00
BidN/A x N/A
AskN/A x N/A
Day's range61.00 - 61.00
52-week range59.90 - 84.04
Volume57
Avg. volume5,206
Market cap17.875B
Beta (5Y monthly)0.98
PE ratio (TTM)17.66
EPS (TTM)3.45
Earnings dateN/A
Forward dividend & yield1.40 (2.30%)
Ex-dividend date13 May 2022
1y target estN/A
  • Business Wire

    Fresenius Medical Care Celebrates Diversity and Unity of a Global Nurse Workforce

    HONG KONG, May 12, 2022--Fresenius Medical Care, the world’s leading provider of products and services for individuals with renal diseases, today announced its global ‘United in Care’ campaign that celebrates the diversity, unity and positive impact of its nurses and clinical teams across Asia Pacific, Europe, the Middle East and Africa, North America and Latin America.

  • Zacks

    Fresenius Medical (FMS) Q1 Earnings & Revenues Top Estimates

    Fresenius Medical's (FMS) first-quarter earnings benefit from strong performance across all the geographic regions and segments.

  • Reuters

    Fresenius warns of bigger Ukraine war impact after Q1 profit beat

    German healthcare group Fresenius's first-quarter profit exceeded market expectations on Wednesday, driven by growth in its generic infusion drugs unit in emerging markets. However, the group warned cost inflation and supply chain disruptions were likely to increase this year, fuelled by Russia's invasion of Ukraine. Fresenius's businesses include the Helios hospital chain, drugmaker Kabi, medical services firm Vamed and dialysis specialist Fresenius Medical Care (FMC).